[
  {
    "ts": null,
    "headline": "Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains",
    "summary": "Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=716986e3709c24681159d7265479225757c5374d4975f3cbec748defb111b257",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731688260,
      "headline": "Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains",
      "id": 131413908,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=716986e3709c24681159d7265479225757c5374d4975f3cbec748defb111b257"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Guggenheim Global Healthcare Conference (Transcript)",
    "summary": "Johnson &amp; Johnson (NYSE:JNJ) Guggenheim Global Healthcare Conference November 12, 2024 10:30 AM ETCompany ParticipantsBiljana Naumovic - Worldwide VP,...",
    "url": "https://finnhub.io/api/news?id=61c881a5f6fbe30287f09a792508597cf5a634ab1c126fd413eb43ea33e2d802",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731680125,
      "headline": "Johnson & Johnson (JNJ) Guggenheim Global Healthcare Conference (Transcript)",
      "id": 131376655,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Johnson &amp; Johnson (NYSE:JNJ) Guggenheim Global Healthcare Conference November 12, 2024 10:30 AM ETCompany ParticipantsBiljana Naumovic - Worldwide VP,...",
      "url": "https://finnhub.io/api/news?id=61c881a5f6fbe30287f09a792508597cf5a634ab1c126fd413eb43ea33e2d802"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program",
    "summary": "Eli Lilly became the second drugmaker this week to sue the U.S. government for rejecting their proposed changes to a program that requires selling discounted drugs to certain medical facilities.",
    "url": "https://finnhub.io/api/news?id=3e7b0631b7e92536cb51cb07fad9301912060ffea2d0b18a3cb8a9c81667c812",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731679333,
      "headline": "Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program",
      "id": 131375244,
      "image": "https://www.investopedia.com/thmb/vsYG-gCJGNtOiilNTZfgwn2tJns=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2183999853-a2fffbde988c49b0a85ced3313519efb.jpg",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Eli Lilly became the second drugmaker this week to sue the U.S. government for rejecting their proposed changes to a program that requires selling discounted drugs to certain medical facilities.",
      "url": "https://finnhub.io/api/news?id=3e7b0631b7e92536cb51cb07fad9301912060ffea2d0b18a3cb8a9c81667c812"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson MedTech announces partnership for soft tissue solutions",
    "summary": "The collaboration will provide advanced soft tissue repair solutions for shoulder, foot and ankle procedures.",
    "url": "https://finnhub.io/api/news?id=9dffaf160b68890cbdf6f8547762fe11ef47b03a2638bd9452c2e67c627c3e36",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731673415,
      "headline": "Johnson & Johnson MedTech announces partnership for soft tissue solutions",
      "id": 131379819,
      "image": "https://www.medicaldevice-network.com/wp-content/uploads/sites/23/2024/11/Johnson-Johnson-MedTech-announces-partnership-for-soft-tissue-solutions-_shutterstock_2464407357.jpg",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The collaboration will provide advanced soft tissue repair solutions for shoulder, foot and ankle procedures.",
      "url": "https://finnhub.io/api/news?id=9dffaf160b68890cbdf6f8547762fe11ef47b03a2638bd9452c2e67c627c3e36"
    }
  },
  {
    "ts": null,
    "headline": "J&J’s nipocalimab shows promise in Phase II Sjögren’s disease trial",
    "summary": "The trial met its primary endpoint, a change in the baseline ClinESSDAI score at week 24.",
    "url": "https://finnhub.io/api/news?id=c2fc914f5dbe1c5aa8b3d91c678accca9c0cddb087565f8d97d5f12d01537e3c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731671518,
      "headline": "J&J’s nipocalimab shows promise in Phase II Sjögren’s disease trial",
      "id": 131379821,
      "image": "https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2024/11/CTA-2-JJ-SjD-trial-Shutterstock_421937950.jpg",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The trial met its primary endpoint, a change in the baseline ClinESSDAI score at week 24.",
      "url": "https://finnhub.io/api/news?id=c2fc914f5dbe1c5aa8b3d91c678accca9c0cddb087565f8d97d5f12d01537e3c"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson : CHMP recommends RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first line treatment of patients with EGFR mutated advanced non small cell lung cancer",
    "summary": "Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the Marketing...",
    "url": "https://finnhub.io/api/news?id=4e951d8ec54f77f4ed1e7749abe48eebdf5a3604f8affcf1c416acc55d441528",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731668407,
      "headline": "Johnson & Johnson : CHMP recommends RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first line treatment of patients with EGFR mutated advanced non small cell lung cancer",
      "id": 131371762,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the Marketing...",
      "url": "https://finnhub.io/api/news?id=4e951d8ec54f77f4ed1e7749abe48eebdf5a3604f8affcf1c416acc55d441528"
    }
  },
  {
    "ts": null,
    "headline": "How To Invest $100,000 In Large Cap Stocks: A Tax-Efficient Advisor-Less Strategy",
    "summary": "This DIY market index strategy blends large-cap stocks and ETFs, plus tax loss harvesting. Read how you can save on fees and manage your own portfolio.",
    "url": "https://finnhub.io/api/news?id=8341c76eb768a3c3450127c2b3d77bebe3f33ada16d4b0b092714778146d3d1d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731664658,
      "headline": "How To Invest $100,000 In Large Cap Stocks: A Tax-Efficient Advisor-Less Strategy",
      "id": 131370892,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1887469204/image_1887469204.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "This DIY market index strategy blends large-cap stocks and ETFs, plus tax loss harvesting. Read how you can save on fees and manage your own portfolio.",
      "url": "https://finnhub.io/api/news?id=8341c76eb768a3c3450127c2b3d77bebe3f33ada16d4b0b092714778146d3d1d"
    }
  },
  {
    "ts": null,
    "headline": "2 Of The Cheapest, High-Quality Dividend Stocks On The Market",
    "summary": "Read an analysis on two dividend stocks with growth potential and inflation protection, designed to thrive in today's market for stable income.",
    "url": "https://finnhub.io/api/news?id=e54df6aa180f8724c2015127dce3bb9b6b7a533f5b6a8a70faaf57b87d2fd8c0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731655800,
      "headline": "2 Of The Cheapest, High-Quality Dividend Stocks On The Market",
      "id": 131368594,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1079164438/image_1079164438.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Read an analysis on two dividend stocks with growth potential and inflation protection, designed to thrive in today's market for stable income.",
      "url": "https://finnhub.io/api/news?id=e54df6aa180f8724c2015127dce3bb9b6b7a533f5b6a8a70faaf57b87d2fd8c0"
    }
  },
  {
    "ts": null,
    "headline": "Fidelity Value Discovery Fund Q3 2024 Review",
    "summary": "On the positive side, the fund benefited from favorable stock picking in industrials, health care and information technology, as well as an underweight in the last of these three sectors.",
    "url": "https://finnhub.io/api/news?id=1aa51c77728b92cd901727e88b352448301e76a8f6d2d4980bd341be7418f764",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731653100,
      "headline": "Fidelity Value Discovery Fund Q3 2024 Review",
      "id": 131367643,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "On the positive side, the fund benefited from favorable stock picking in industrials, health care and information technology, as well as an underweight in the last of these three sectors.",
      "url": "https://finnhub.io/api/news?id=1aa51c77728b92cd901727e88b352448301e76a8f6d2d4980bd341be7418f764"
    }
  },
  {
    "ts": null,
    "headline": "Intuitive Surgical: The Price For Its Excellence Is Too High",
    "summary": "Is Intuitive Surgical a buy or hold? Find out why the leading robotic surgery company may be overvalued and whether it's worth waiting for a better entry.",
    "url": "https://finnhub.io/api/news?id=7b117a20f7240c96cf3477b2cd878461d2c6199637d4cef3f93e3eb14e251676",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731637463,
      "headline": "Intuitive Surgical: The Price For Its Excellence Is Too High",
      "id": 131364079,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1922015225/image_1922015225.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Is Intuitive Surgical a buy or hold? Find out why the leading robotic surgery company may be overvalued and whether it's worth waiting for a better entry.",
      "url": "https://finnhub.io/api/news?id=7b117a20f7240c96cf3477b2cd878461d2c6199637d4cef3f93e3eb14e251676"
    }
  }
]